对于 AECOPD 患者,你也常常雾化联合静脉激素治疗吗? 欢迎评论区留言讨论~ 参考文献 1. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(2022 REPORT)[EB/OL]. [2021‐11‐15]. https:///2022-gold-reports/. 2. 中华医学会呼吸病学分会慢性阻塞性肺疾病学组; 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会; 慢性阻塞性肺疾病诊治指南 (2021 年修订版). 中华结核和呼吸杂志 2021:170–205. 3. Sun X, He Z, Zhang J, Deng J, Bai J, Li M, et al. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD. Pulmonary Pharmacology & Therapeutics 2015;31:111–6. doi: 10.1016/j.pupt.2014.09.004. 4. Ding Z, Li X, Lu Y, Rong G, Yang R, Zhang R, et al. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2016;121:39–47. doi: 10.1016/j.rmed.2016.10.013. 5. Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2002;165:698–703. doi: 10.1164/ajrccm.165.5.2109093. 6. 慢性阻塞性肺疾病糖皮质激素规范管理撰写组; 慢性阻塞性肺疾病糖皮质激素规范管理专家共识(2021 版). The optimal use of glucocorticoids for patients with chronic obstructive pulmonary disease: a Chinese expert consensus(2021) 2021;44:1054–63. doi: 10.3760/cma.j.cn112147-20210802-00543. |
|